What the S&P 500, VIX, and ARKK are Telling Us Now

Read more

RRG Update: Is Tech Ready to Break Out?

Read more

HyProMag USA Receives “Make More in America” Domestic Finance Letter of Interest for up to US$92 Million From US EXIM Bank

Read more

Empire Metals Limited Announces Warrant Exercise

Read more

Juggernaut Files for Approval of Private Placement Financing

Read more

Harvest Gold Identifies 15 Primary And 10 Secondary Targets For Its Diamond Drill Program At Its Mosseau Project In Quebec

Read more

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

by admin June 4, 2025

June 4, 2025

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com

previous post

Operational Update

next post

S&P 500 Bullish Patterns: Are Higher Highs Ahead?